Suspended
A Randomized, Multi-center, Double-blind, Placebo Controlled, Dose Ranging Study With VSL#3 in Diarrhea Predominant IBS Patients
What is being tested
Data Collection
Who is being recruted
Diarrhea+1
+ Signs and Symptoms
+ Signs and Symptoms, Digestive
Over 18 Years
+4 Eligibility Criteria
How is the trial designed
Treatment Study
Interventional
Study Start: January 2005
Summary
Principal SponsorBeth Israel Deaconess Medical Center
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner
Study start date: January 1, 2005
Actual date on which the first participant was enrolled.The study will evaluate 2 doses of VSL#3 and placebo over a 4 week period in patients presenting with diarrhea predominant IBS symptoms.
Official TitleA Randomized, Multi-center, Double-blind, Placebo Controlled, Dose Ranging Study With VSL#3 in Diarrhea Predominant IBS Patients
Principal SponsorBeth Israel Deaconess Medical Center
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
180 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
DiarrheaSigns and SymptomsSigns and Symptoms, DigestivePathological Conditions, Signs and Symptoms
Criteria
1 inclusion criteria required to participate
IBS diarrhea
3 exclusion criteria prevent from participating
18 years of age
Pregnancy/breast feeding
concomitant medications to reduce bowel function
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Suspended
SuspendedOne Study Center